article Open AccessTop 1% cited
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
BMC Cancer · 2009 · Vol. 9(1) · pp. 86–86
S. R. Young✉(University of South Carolina)Robert Pilarski(Cancer Genetics (United States))Talia Donenberg(University of Miami)Charles L. Shapiro(The Ohio State University)Lyn S. Hammond(Medical University of South Carolina)Judith Miller(University of Illinois Chicago)Karen Brooks(University of South Carolina)Stephanie A. Cohen(St Vincent Hospital)Beverly Tenenholz(Geisinger Medical Center)Damini DeSaiInuk Zandvakili(University of Toronto)Robert E. Royer(University of Toronto)Song Li(Women's College Hospital)Steven A. Narod(University of Toronto)
Abstract
Women with early-onset triple-negative breast cancer are candidates for genetic testing for BRCA1, even in the absence of a family history of breast or ovarian cancer.
BRCA gene mutations in cancerCancer Genomics and DiagnosticsDNA Repair MechanismsTriple-negative breast cancerSurgical oncologyMedicineBreast cancerOncologyInternal medicineCancer
MeSH terms
AdultBreast NeoplasmsDNA Mutational AnalysisFemaleGene FrequencyGenetic TestingHumansMutationReceptors, EstrogenReceptors, ProgesteroneErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2BRCA1 ProteinYoung Adult
Funding
- Ohio State University
Citations
273
FWCI
14.01
field-weighted impact
References
24
Percentile
99%
vs. same field & year
Citations per year
References
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
Clinical Cancer Research · 2007 · 5,037 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.